Summit Global Investments

Source: SEC Form 13F · as of Mar 2026

Summit Global Investments holds 37 biotech & pharma companies tracked by BioSniper, totaling $77K in value as of Mar 2026 (SEC Form 13F).

Companies held

37

Total value held

$77K

CompanySharesValue
LLYELI LILLY & Co10,816$10K
MRKMerck & Co., Inc.67,598$8K
REGNREGENERON PHARMACEUTICALS, INC.9,804$8K
INCYIncyte Corp.56,059$5K
BMRNBIOMARIN PHARMACEUTICAL INC79,055$4K
UTHRUNITED THERAPEUTICS Corp5,917$4K
ABBVAbbVie Inc.14,575$3K
CAHCardinal Health Inc.14,603$3K
CORCencora Inc.9,130$3K
JNJJOHNSON & JOHNSON10,332$3K
NBIXNEUROCRINE BIOSCIENCES INC17,083$2K
MCKMcKesson Corporation2,549$2K
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)116,494$2K
UNHUnitedHealth Group Incorporated Common Stock (DE)6,520$2K
VRTXVERTEX PHARMACEUTICALS INC / MA3,896$2K
PFEPFIZER INC60,350$2K
GILDGILEAD SCIENCES, INC.12,051$2K
BMYBRISTOL MYERS SQUIBB CO26,658$2K
PMPhilip Morris International Inc8,074$1K
ELVElevance Health Inc.4,421$1K
AMGNAMGEN INC2,905$1K
ABTABBOTT LABORATORIES8,337$856
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)15,004$828
HRMYHarmony Biosciences Holdings, Inc.27,034$757
AZNASTRAZENECA PLC3,826$755
RDYDR REDDYS LABORATORIES LTD53,845$746
GMOptec International, Inc.8,863$660
CPRXCATALYST PHARMACEUTICALS, INC.23,573$584
INVAInnoviva, Inc.23,626$550
NVSNovartis AG2,716$415
ALKSAlkermes plc.11,691$413
LGNDLigand Pharmaceuticals Incorporated1,937$387
CSTLCastle Biosciences Inc.13,718$337
VMDViemed Healthcare Inc.32,640$301
SUPNSUPERNUS PHARMACEUTICALS, INC.4,436$229
PTCTPTC THERAPEUTICS, INC.3,173$216
MNKDMANNKIND CORP13,901$34

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Summit Global Investments — Biotech 13F Holdings & Portfolio | BioSniper